Clinical Trial Update: CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating CLAG-M or FLAG-Ida chemotherapy with reduced-intensity conditioning donor stem cell transplant for relapsed or refractory acute my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• CLAG-M regimen
• FLAG-Ida regimen (Fludarabine, cytarabine, idarubicin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia | Phase 1 | Status: RECRUITING